Skip to content

Brensocatib

Drug profile

Also known as: AZD7986, brinsupri, INS1007

OnpEMA approvedFDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Brensocatib is an onp drug catalogued in DrugCentral. It was first approved by the FDA in 2025. DrugCentral lists 3 molecular targets, including CTSC, Ctsc and Ctsc. Recorded indications include Non-cystic fibrosis bronchiectasis.

  • Approval status: onp (first approved 2025 by the FDA).
  • Molecular targets: CTSC, Ctsc and Ctsc (3 listed in DrugCentral).
  • Indications: Non-cystic fibrosis bronchiectasis.
  • Molecular formula: C23H24N4O4; molecular weight 420.47 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Non-cystic fibrosis bronchiectasis

Mechanism & targets

Molecular targets (3)

TargetGeneActionActivity
Dipeptidyl peptidase 1CTSCinhibitorIC50 8.40
Dipeptidyl peptidase 1CtscinhibitorIC50 7.70
Dipeptidyl peptidase 1CtscinhibitorIC50 7.60

Regulatory approvals (2)

DateAgencyMarketed asApplicantOrphan
2025-11-18EMA—Insmed Netherlands B.V.
2025-08-12FDA—Insmed Inc.

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Brensocatib is on its molecule page.

Molecular formulaC23H24N4O4
Molecular weight420.47 g/mol
CAS number—
InChIKeyAEXFXNFMSAAELR-RXVVDRJESA-N
PubChem CID118253852
CN1C2=C(C=CC(=C2)C3=CC=C(C=C3)C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)OC1=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Brensocatib used for?

DrugCentral lists the following indications for Brensocatib: Non-cystic fibrosis bronchiectasis.

How does Brensocatib work?

Its molecular targets in DrugCentral include CTSC (inhibitor), Ctsc (inhibitor) and Ctsc (inhibitor).

When was Brensocatib first approved?

Brensocatib was first approved by the FDA in 2025.

What is the chemical formula of Brensocatib?

Brensocatib has the molecular formula C23H24N4O4 and a molecular weight of 420.47 g/mol.

Browse: all drugs starting with B · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusONP
First approval2025-08-12
AgencyFDA
Targets3
Indications1
FormulaC23H24N4O4
DrugCentral ID5791
Interactive profile